Patents by Inventor Pia Kasperkovitz

Pia Kasperkovitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosages and methods for delivering lipid formulated nucleic acid molecules
    Patent number: 11827883
    Abstract: Methods, kits and devices for dosing a subject to reduce a hypersensitivy response to a lipid-formulated nucleic acid (e.g., RNA) molecule are disclosed.
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: November 28, 2023
    Assignee: Alnylam Pharmaceuticals, Inc.
    Inventors: Pia Kasperkovitz, Jared Gollob
  • DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES
    Publication number: 20210388355
    Abstract: Methods, kits and devices for dosing a subject to reduce a hypersensitivy response to a lipid-formulated nucleic acid (e.g., RNA) molecule are disclosed.
    Type: Application
    Filed: April 8, 2021
    Publication date: December 16, 2021
    Inventors: Pia Kasperkovitz, Jared Gollob
  • DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES
    Publication number: 20190284557
    Abstract: Methods, kits and devices for dosing a subject to reduce a hypersensitivy response to a lipid-formulated nucleic acid (e.g., RNA) molecule are disclosed.
    Type: Application
    Filed: January 29, 2019
    Publication date: September 19, 2019
    Inventors: Pia Kasperkovitz, Jared Gollob
  • Dosages and methods for delivering lipid formulated nucleic acid molecules
    Patent number: 10246708
    Abstract: Methods, kits and devices for dosing a subject to reduce a hypersensitivity response to a lipid-formulated nucleic acid (e.g., RNA) molecule are disclosed.
    Type: Grant
    Filed: May 6, 2014
    Date of Patent: April 2, 2019
    Assignee: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Pia Kasperkovitz, Jared Gollob
  • DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES
    Publication number: 20160122759
    Abstract: Methods, kits and devices for dosing a subject to reduce a hypersensitivity response to a lipid-formulated nucleic acid (e.g., RNA) molecule are disclosed.
    Type: Application
    Filed: May 6, 2014
    Publication date: May 5, 2016
    Applicant: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Pia Kasperkovitz, Jared Gollob